Pfizer Buy, Sell, Hold: 2026 Stock Outlook and Strategy
Pfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
This article outlines typical volatile periods for SP 500 and how retirees can position portfolios to endure drawdowns while meeting needs.
26,423 articlesPfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Barrick mining stock sinking this week is a reminder that miners ride metal prices as much as earnings. Here’s what’s...
Joe Kent, a former Army Special Forces officer and two-time congressional candidate, quit today from a top counterter...
Investing in obesity drugs doesn't have to be a gamble. This guide explains why a proven company with real cash flow ...
A senior strategist at a massive $1.8 trillion fund warns that long-dated Treasuries are unlikely to shield retiremen...
A prompt-driven AI model inspired by Altman and CHATGPT outlines a potential XRP breakout by the end of June 2026. Th...
Investors are buzzing as SAIC reports stronger-than-expected results and a growing federal pipeline. This article bre...
SOXX and SMH track similar themes but differ in holdings breadth and index rules, fueling a clear performance split i...
I once believed SpaceX would be a slam-dunk winner for investors. Then I realized a careful, staged approach beats ri...
As memory cycles swing, the safest play in July may not be the pure-play chips you expect. This article explains why ...
Oklo has shed 28% over the past month as investors rotate away from pre-revenue nuclear developers. Utilities remain ...